[Biopharmaceutic aspects of prolonged-release formulations with a methylxanthine base. I].
Ventouras
K
K
Gueurten
D
D
Jaminet
F
F
D001702:Biopharmaceutics; D003692:Delayed-Action Preparations; D014970:Xanthines / Q000008:administration & dosage / Q000493:pharmacokinetics*
D003692:Delayed-Action Preparations; D014970:Xanthines; C008514:methylxanthine
Aspects biopharmaceutiques de formulations à libération prolongée à base de méthylxanthines. I.